Screener
ImmunityBio, Inc. IBRX Non-Controlling Interests
Non-Controlling Interests at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Common Stock, $0.0001 par value; 1,650,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 1,047,341,146 and 1,011,800,008 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively; excluding treasury stock, 163,800 shares outstanding as of March 31, 2026 and December 31, 2025 | $104 | $101 |
| Additional paid-in capital | 3,461,865 | 3,197,120 |
| Accumulated deficit | (4,359,428) | (3,726,646) |
| Accumulated other comprehensive income | 27,453 | 28,956 |
| Total ImmunityBio stockholders’ deficit | (870,006) | (500,469) |
| Noncontrolling interests | 880 | 895 |
| Total stockholders’ deficit | (869,126) | (499,574) |
| Total liabilities and stockholders’ deficit | $646,637 | $501,898 |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s non-controlling interests?
- ImmunityBio, Inc. (IBRX) reported non-controlling interests of $880K in Q1 2026.
- How has ImmunityBio, Inc.'s non-controlling interests changed year-over-year?
- ImmunityBio, Inc.'s non-controlling interests decreased by 7.3% year-over-year, from $949K to $880K.
- What is the long-term trend for ImmunityBio, Inc.'s non-controlling interests?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s non-controlling interests has grown at a -7.4% compound annual growth rate (CAGR), from $1.32M to $895K.
- What does non-controlling interests mean?
- Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.
Ask your AI about ImmunityBio, Inc.'s non-controlling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude